Neck News and Research

RSS

Unique genetic markers point to patient response to SCV-07 treatment

SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that researchers have identified two unique gene clusters that differentiated subjects who responded to treatment in the Company’s phase 2a proof of concept study of SCV-07 for the prevention of severe oral mucositis (OM; WHO grades 3-4) in patients with advanced head and neck cancer.

29 Sep 2010

Children younger than 5 years account for over half of bathtub- and shower-related injuries

Bathtubs and showers are frequently associated with injuries to children. Although interventions have been initiated to prevent injuries due to submersions and hot water scalds, little attention has been paid to slips, trips and falls, which account for more than 80 percent of bathtub- and shower-related injuries.

29 Sep 2010

IsoRay reports increase revenue for 2010 fiscal year

IsoRay Inc. a medical isotope company and the exclusive manufacturer of Cesium-131 used in internal radiation therapy for the treatment of lung, colon, head and neck, and prostate cancers, ocular melanoma, and other malignant disease through the use of its proprietary radioisotope technology, announced its financial results for the year ended June 30, 2010.

28 Sep 2010

Acclarent's new technologies improve visualization during sinus surgery

Acclarent, Inc., a leader in minimally-invasive sinus surgery, today announced the introduction of two new technologies designed to improve visualization during sinus surgery The Acclarent Cyclops Multi-Angle Endoscope and the Relieva Luma Sentry Sinus Illumination System.

28 Sep 2010

TONES procedure is safe and effective for treating brain diseases, traumatic injuries

Surgeons at the University of California, San Diego, School of Medicine and University of Washington Medical Center have determined that transorbital neuroendoscopic surgery is a safe and effective option for treating a variety of advanced brain diseases and traumatic injuries. This groundbreaking minimally invasive surgery is performed through the eye socket, thus eliminating the removal of the top of the skull to access the brain.

27 Sep 2010

Researchers find no correlation between genetic ancestry and cancer stage

Head and neck cancer outcomes associated with race may be more closely linked to social and behavioral factors than biological differences, especially for African Americans, according to a new Henry Ford Hospital study.

27 Sep 2010

Researchers synthesize molecule to block abnormal protein in cancer cells

In the quest to arrest the growth and spread of tumors, there have been many attempts to get cancer genes to ignore their internal instruction manual. In a new study, a team led by Dana-Farber Cancer Institute scientists has created the first molecule able to prevent cancer genes from "hearing" those instructions, stifling the cancer process at its root.

27 Sep 2010

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.

22 Sep 2010

Stanford Cancer Center announces successful treatment of 5,000th patient with CyberKnife system

When Lori Brownell's first tumor appeared − on her left carotid artery − it was surgically removed, leaving an inches-long incision to heal. It was eight years before the feeling returned to that side of her neck, and for a time, she couldn't drive because she couldn't turn her head far enough.

21 Sep 2010

New body-contouring laser causes fat loss

Stephanie Martinez had one of the most universal desires - to shed a few stubborn inches from her waist, hips and thighs - without harsh diets, needles or other surgical interventions that require staying at home and taking time off from work.

20 Sep 2010

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that for the first time in Europe the company showcased its latest offering, the CyberKnife VSI System, at ESTRO 29, the Annual Congress of the European Society for Therapeutic Radiology and Oncology in Barcelona, Spain.

18 Sep 2010

GORE C3 Delivery System enables repositioning of stent graft during procedure for AAA

W. L. Gore & Associates (Gore) today announced the first clinical uses of the GORE C3 Delivery System to deploy the GORE EXCLUDER AAA Endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA).

16 Sep 2010

Access Pharmaceuticals launches product website for MuGard

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today it has launched www.MuGard.com. The patient- and healthcare professional- focused site is a comprehensive resource offering educational material on oral mucositis, patient analysis, MuGard product and how-to-order information.

15 Sep 2010

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

The recent news that Michael Douglas has been diagnosed with stage 4 throat cancer has raised public awareness of head and neck cancer. What causes throat cancer and what are the symptoms? Are there ways to prevent or reduce the risk of throat cancer? How is the human papillomavirus (HPV) related to oral cancer?

14 Sep 2010

North Mississippi IRB approves CEL-SCI's Multikine Phase III clinical trial for head and neck cancer

CEL-SCI Corporation announced today it has received approval from the North Mississippi Health Services Institutional Review Board ("IRB") to begin enrollment of subjects for a Phase III clinical trial of Multikine®, the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. An IRB is a group formally designated by an institution to review and monitor research involving human subjects and to ensure protection of their rights and welfare.

13 Sep 2010

FDA approves Abreu BTT 700 System for temperature monitoring

Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.

10 Sep 2010

Neck manipulation may be risky without significant benefits: Study

According to new research manipulation for neck pain may carry a risk of serious injury, including stroke. For the study more than 120 patients with neck pain were included. They were randomly assigned to be treated with either manipulation or mobilization - which involves small, rhythmic movements applied to stiff or inflamed tissue. The outcome of both groups was almost identical, prompting researchers to conclude that manipulation may not be worth the risk.

8 Sep 2010

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

An incisionless robotic surgical procedure is offering patients a new option to remove certain head and neck cancer tumors without visible scarring, while preserving speech and the ability to eat.

8 Sep 2010

Ultrasound guidance helps radiologist to identify, treat self-embedding patients

Using ultrasound and a minimally-invasive procedure, radiologists can identify and treat patients who engage in a disturbing self-injury behavior known as self-embedding, according to a new study published in the online edition and October print issue of the journal Radiology.

7 Sep 2010

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Only one in ten people know that radiotherapy helps cure forty per cent of cancer patients according to new figures published by Cancer Research UK today.

7 Sep 2010

Neck News and Research

Unique genetic markers point to patient response to SCV-07 treatment

Children younger than 5 years account for over half of bathtub- and shower-related injuries

IsoRay reports increase revenue for 2010 fiscal year

Acclarent's new technologies improve visualization during sinus surgery

TONES procedure is safe and effective for treating brain diseases, traumatic injuries

Researchers find no correlation between genetic ancestry and cancer stage

Researchers synthesize molecule to block abnormal protein in cancer cells

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Stanford Cancer Center announces successful treatment of 5,000th patient with CyberKnife system

New body-contouring laser causes fat loss

Accuray Incorporated showcases CyberKnife VSI System at ESTRO Annual Congress

GORE C3 Delivery System enables repositioning of stent graft during procedure for AAA

Access Pharmaceuticals launches product website for MuGard

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

North Mississippi IRB approves CEL-SCI's Multikine Phase III clinical trial for head and neck cancer

FDA approves Abreu BTT 700 System for temperature monitoring

Neck manipulation may be risky without significant benefits: Study

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

Ultrasound guidance helps radiologist to identify, treat self-embedding patients

Survey reveals lack of public awareness about radiotherapy's importance in treating cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News